← back to search

Rafael López Castro

Universidad de Valladolid · ES
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, and Lung Cancer Research Studies.
h-index
20
citations
2,101
works
205
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations
European Journal of Cancer 2022cited by 53position: middledoi
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
Annals of Oncology 2020cited by 271position: middledoi
A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
Annals of Oncology 2019cited by 55position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

A. Roy · Sylhet MAG Osmani Medical College2 papers (2019–2020)A. Pope · Clatterbridge Cancer Centre NHS Foundation Trust2 papers (2019–2020)P.M. Fisher · Sheffield Teaching Hospitals NHS Foundation Trust2 papers (2019–2020)Wolf-Dieter Janthur · Kantonsspital Aarau2 papers (2019–2020)Rosario García Campelo · Instituto de Investigación Biomédica de A Coruña2 papers (2019–2020)Mary O’Brien · Imperial College London2 papers (2019–2020)Rolf A. Stahel · International Breast Cancer Study Group2 papers (2019–2020)Ernest Nadal · Universitat de Barcelona2 papers (2019–2020)Sylvie Rusakiewicz · University Hospital of Lausanne2 papers (2019–2020)Heidi Roschitzki‐Voser · International Breast Cancer Study Group2 papers (2019–2020)David Gilligan · University of Cambridge2 papers (2019–2020)Barbara Ruepp · Frontier Science Foundation-Hellas2 papers (2019–2020)Varvara Polydoropoulou · Frontier Science Foundation-Hellas2 papers (2019–2020)James Spicer · King's College London2 papers (2019–2020)Alessandra Curioni‐Fontecedro · University of Fribourg2 papers (2019–2020)Sanjay Popat · Royal Marsden NHS Foundation Trust2 papers (2019–2020)Solange Peters · Hôpital Beau-Séjour2 papers (2019–2020)Oliver Gautschi · University of Bern2 papers (2019–2020)— · 1 papers (2019–2019)R. Shah · Maidstone and Tunbridge Wells NHS Trust1 papers (2020–2020)